VOYA Investment Management’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.9M Buy
122,227
+94,093
+334% +$29.8M 0.04% 352
2026
Q1
$9.06M Buy
28,134
+14,479
+106% +$4.48M 0.01% 653
2025
Q4
$4.02M Buy
+13,655
New +$2.54M ﹤0.01% 948
2025
Q3
– Sell
-4,919
Closed -$207K – 2600
2025
Q2
$207K Buy
+4,919
New +$187K ﹤0.01% 2315
2025
Q1
– Sell
-5,228
Closed -$402K – 2713
2024
Q4
$402K Sell
5,228
-441
-8% -$31.9K ﹤0.01% 2039
2024
Q3
$326K Sell
5,669
-155
-3% -$8.37K ﹤0.01% 2226
2024
Q2
$241K Buy
+5,824
New +$275K ﹤0.01% 2374
2023
Q2
– Sell
-1,281
Closed -$15.5K – 2979
2023
Q1
$15.5K Buy
1,281
+76
+6% +$3.21K ﹤0.01% 2877
2022
Q4
$43K Buy
+1,205
New +$37.6K ﹤0.01% 2865
2022
Q2
– Sell
-836
Closed -$128K – 2865
2022
Q1
$128K Hold
836
– – ﹤0.01% 2476
2021
Q4
$247K Buy
836
+39
+5% +$11.4K ﹤0.01% 2397
2021
Q3
$221K Buy
+797
New +$216K ﹤0.01% 2513
2021
Q1
– Sell
-264
Closed -$218K – 2768
2020
Q4
$218K Buy
+264
New +$154K ﹤0.01% 2379

Other funds holding PRAX

VOYA Investment Management's PRAX Position: Q2 2026 in Review

VOYA Investment Management increased its Praxis Precision Medicines (PRAX) stake by 334% in Q2 2026, buying an estimated $29.8M and bringing the position to 122,227 shares worth $40.9M. The position accounts for 0.04% of the portfolio, ranked #352.

VOYA Investment Management first reported a position in PRAX in Q4 2020 and has held it in 13 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • VOYA Investment Management held 122,227 shares of Praxis Precision Medicines worth $40.9M as of Q2 2026.
  • VOYA Investment Management bought 94,093 Praxis Precision Medicines shares in Q2 2026, an estimated $29.8M.
  • Praxis Precision Medicines made up 0.04% of VOYA Investment Management's portfolio in Q2 2026, its #352 holding.
  • VOYA Investment Management first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 13 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.